NDC 31722-838 – ABACAVIR and LAMIVUDINE
Abacavir Sulfate 600 mg/1; Lamivudine 300 mg/1 · Tablet, Film Coated · Oral
Product NDC31722-838
Product details
- Brand name
- ABACAVIR and LAMIVUDINE
- Generic name
- ABACAVIR and LAMIVUDINE
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA205412
- Marketed since
- April 16, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Abacavir Sulfate 600 mg/1
- Lamivudine 300 mg/1
Uses, dosage, side effects and warnings for Abacavir and Lamivudine →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 31722-838-30 | 1 BOTTLE in 1 CARTON (31722-838-30) / 30 TABLET, FILM COATED in 1 BOTTLE | Apr 16, 2025 |
Other Abacavir and Lamivudine products
- 65862-335 Abacavir Sulfate 600 mg/1; Lamivudine 300 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 69097-362 Abacavir Sulfate 600 mg/1; Lamivudine 300 mg/1 · Tablet, Film Coated · Cipla USA Inc.
- 42385-962 Abacavir Sulfate 600 mg/1; Lamivudine 300 mg/1 · Tablet, Film Coated · Laurus Labs Limited
- 68180-288 Abacavir Sulfate 600 mg/1; Lamivudine 300 mg/1 · Tablet, Film Coated · Lupin Pharmaceuticals, Inc.
- 33342-440 Abacavir Sulfate 600 mg/1; Lamivudine 300 mg/1 · Tablet, Film Coated · Macleods Pharmaceuticals Limited